Recurring implementation determinants in digital health innovations: a multi-context multiple case study and cross-case synthesis into a four-domain analytical framework - Top-Institutions - MDSpire

Recurring implementation determinants in digital health innovations: a multi-context multiple case study and cross-case synthesis into a four-domain analytical framework

  • By

  • Mariusz Jaworski

  • Petra Petrová

  • Thomas Spittler

  • Radu-George Ciorap

  • Agnieszka Wojtczuk-Turek

  • Ilona Cieslak

  • July 15, 2026

Share

Top Institutions in Internal Medicine

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Public Health
    • Digital Health

  • #2

    Mass General Brigham
    Mass General Brigham

    Boston, Massachusetts

    Key Differentiators

    • Public Health
    • Digital Health

  • #3

    National Health Service
    National Health Service

    London, England

    Key Differentiators

    • Public Health
    • Digital Health

  • #4

    World Health Organization
    World Health Organization

    Geneva, Switzerland

    Key Differentiators

    • Public Health

  • #5

    Centre for eHealth Research
    Centre for eHealth Research

    Amsterdam, Netherlands

    Key Differentiators

    • Public Health
    • Digital Health

Original Source(s)

Recurring implementation determinants in digital health innovations: a multi-context multiple case study and cross-case synthesis into a four-domain analytical framework

  • by Mariusz Jaworski, Petra Petrová, Thomas Spittler, Radu-George Ciorap, Agnieszka Wojtczuk-Turek, Ilona Cieslak

  • July 15, 2026

Related Content

The optimal exercise modality and dose for glycemic control in older adults with type 2 diabetes mellitus: a systematic review and network meta-analysis

Disparities in Delayed Discharge Among Patients Experiencing Homelessness

Molecular mechanisms of suxiao jiuxin pills in ameliorating post-acute myocardial infarction inflammatory response: a combined network pharmacology, Mendelian randomization, and experimental validation study